ReviewInternational journal of cardiology. Cardiovascular risk and prevention2025
Immune responses and activity of inflammatory mediators in pulmonary vein arrhythmogenesis.
Review in International journal of cardiology. Cardiovascular risk and prevention, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Atrial fibrillation (AF) is the most common type of sustained arrhythmia with potentially serious complications and risk of mortality. Inflammation plays an indispensable role in the pathogenesis of AF, evidenced by the elevated levels of various cytokines such as C-reactive protein, macrophage migration inhibitor (MIF), interleukin-6 (Il-6), and tumor necrosis factor-α (TNF-α). Pulmonary veins (PVs) are the main site of AF initiation, where cells acquire arrhythmogenic properties under the effects of pro-inflammatory mediators. Calcium/calmodulin-dependent protein kinase II (CaMKII) signaling also plays a critical role in arrhythmogenesis, which is modulated by aberrant Ca2+ homeostasis and ion currents, as well as the electrophysiological properties of PVs influenced by inflammatory mediators, including MIF. Today, pulmonary vein isolation (PVI) is one of the main treatments for AF. This review aimed to outline our current understanding of the underlying mechanisms of AF in an effort to open a new window for discovering novel therapies for this type of arrhythmia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.